Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
about
WDR5 Expression Is Prognostic of Breast Cancer Outcome.Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structureA-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genesXanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancerFlaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovariesMinireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.In vitro Antiproliferative and Apoptosis Inducing Effect of Allium atroviolaceum Bulb Extract on Breast, Cervical, and Liver Cancer Cells.Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
P2860
Q30402762-F3540B16-8F79-43D8-8A74-F4D0ECF7D22EQ33687329-DB1AF296-E1C8-419C-8B42-18ACE3009605Q33896624-74F9DB33-A377-4209-A97E-3AA3FD16335CQ33908447-4BD8A88D-9409-4043-BD55-92FA2070B990Q34550071-EC35FBC3-1E7C-4161-8C81-9249AED75574Q34648456-5E3A4164-398E-4F4D-AA65-B1A4693E0981Q35656014-8E225A39-BF31-427C-8032-D144B84F9746Q35674177-46806248-0FDE-4B58-9442-920057CDC57EQ36767559-870942F0-697D-44C1-B65F-95429A44D625Q39434758-A0334545-BD13-4315-8887-0C7225F98338Q42325997-99949809-F61C-4D17-80D2-399CD6B91FD3Q55253157-34EC60B4-C4F8-480D-B8FE-E9F403ADB394
P2860
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@en
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@nl
type
label
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@en
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@nl
prefLabel
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@en
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@nl
P2093
P2860
P356
P1476
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
@en
P2093
Eiichi Mizohata
Masato Komatsu
Miki Akiyama
Mitsunori Sasa
Rui Yamaguchi
Seiya Imoto
Taisuke Matsuo
Tetsuro Yoshimaru
Toyomasa Katagiri
Tsuyoshi Inoue
P2860
P2888
P356
10.1038/NCOMMS3443
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1008503019